Jiangsu Hengrui Medicine Co., Ltd. (SHA: 600276)

Jiangsu Hengrui Medicine Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 5, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	282,320	287,598	245,741	323,076	591,745	385,431
Market Cap Growth	-19.95%	17.03%	-23.94%	-45.40%	53.53%	98.44%
Enterprise Value	259,694	270,642	228,393	306,010	576,180	372,593
Last Close Price	44.40	45.01	38.21	50.09	91.52	59.75
PE Ratio	51.54	66.19	62.63	70.55	92.45	71.70
PS Ratio	11.07	12.60	11.55	12.47	21.34	16.55
PB Ratio	6.45	7.01	6.40	9.08	19.22	15.46
P/FCF Ratio	44.54	46.69	-338.06	126.49	205.64	118.39
P/OCF Ratio	31.35	37.63	194.22	76.58	172.42	100.98
EV/Sales Ratio	10.28	11.86	10.74	11.81	20.77	16.00
EV/EBITDA Ratio	42.83	56.03	63.46	71.83	85.74	60.88
EV/EBIT Ratio	48.96	64.81	74.65	81.29	91.87	67.73
EV/FCF Ratio	40.97	43.94	-314.20	119.81	200.23	114.45
Debt / Equity Ratio	0.00	0.00	0.04	0.00	-	-
Debt / EBITDA Ratio	0.02	0.02	0.37	0.04	-	-
Debt / FCF Ratio	0.01	0.01	-1.87	0.06	-	-
Asset Turnover	0.56	0.53	0.52	0.70	0.89	0.93
Inventory Turnover	1.57	1.50	1.44	1.80	1.98	2.21
Quick Ratio	6.37	10.74	7.36	7.72	6.70	8.08
Current Ratio	7.23	12.25	8.50	8.87	7.44	9.02
Return on Equity (ROE)	13.11%	10.77%	10.31%	13.51%	22.64%	23.81%
Return on Assets (ROA)	7.36%	6.06%	4.68%	6.36%	12.59%	13.78%
Return on Capital (ROIC)	8.01%	6.45%	5.07%	7.08%	14.07%	15.37%
Earnings Yield	1.94%	1.50%	1.59%	1.40%	1.07%	1.38%
FCF Yield	2.24%	2.14%	-0.30%	0.79%	0.49%	0.84%
Dividend Yield	0.45%	0.44%	0.42%	0.32%	0.18%	0.27%
Payout Ratio	0.73%	23.77%	26.00%	23.54%	16.07%	15.22%
Buyback Yield / Dilution	1.56%	1.20%	-0.37%	0.18%	0.02%	-0.48%
Total Shareholder Return	2.01%	1.64%	0.05%	0.50%	0.21%	-0.21%

Source: S&P Capital IQ. Standard template. Financial Sources.